← 產業報告目錄

Ophthalmic Imaging Market by Product Type (Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras), Application (Glaucoma, Retinopathies), End User (Hospitals, Ophthalmology Clinics, Optometry Clinics) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-09-03頁數 344報告編號 MD9479

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The ophthalmic imaging market is projected to reach USD 3.84 billion by 2030 from USD 2.83 billion in 2025, at a CAGR of 6.3% during the forecast period. The ophthalmic imaging market is driven by the growing prevalence of eye diseases such as glaucoma, diabetic retinopathy, and age-related macular degeneration, particularly among the aging global population. Increasing demand for early and accurate diagnosis, advancements in imaging technologies like OCT and fundus cameras, and rising awareness of preventive eye care are boosting market growth. Additionally, favorable government initiatives and rising healthcare expenditure support market expansion. However, high equipment costs, limited reimbursement in certain regions, and a shortage of skilled professionals restrain widespread adoption, especially in low-income and rural settings. Data management and integration challenges in clinical workflows further limit efficiency in some healthcare facilities. Opportunities lie in the development of portable, AI-integrated imaging devices and the expansion of teleophthalmology services to reach underserved populations. Based on product, the OCT systems segment is expected to have the highest growth rate during the forecast year. Optical coherence tomography (OCT) systems are expected to grow at the highest CAGR during the forecast period because they offer non‑invasive, ultra‑high-resolution imaging essential for early diagnosis of retinal and optic nerve diseases. Technological advances—such as swept‑source OCT, OCT-angiography, and AI‑driven analytics—enhance diagnostic capability and workflow efficiency. Compact, handheld OCT devices are expanding access in primary care and rural settings. The growing global prevalence of diabetes, glaucoma, and AMD, combined with rising healthcare investments and favorable reimbursements, further drives OCT adoption and rapid market expansion. Based on end user, the optometry clinics segment is expected to have the highest growth rate during the forecast year due to increasing consumer awareness of eye health and routine vision screenings. They serve as primary care hubs, offering accessible and affordable eye examinations. The rising adoption of portable, high-resolution diagnostic devices such as OCT, fundus cameras, and visual field analyzers in clinics further accelerates this trend. Clinics are increasingly investing in AI-enabled, compact equipment to enhance workflow efficiency and deliver rapid diagnostics. Additionally, growth in tele-optometry and remote screening models supports scalable reach, particularly in underserved regions, driving sustained clinic-based expansion. Asia Pacific is expected to have the highest growth rate during the forecast period due to a rapidly aging population, rising prevalence of eye disorders like glaucoma, cataracts, and diabetic retinopathy, and increasing investment in healthcare infrastructure across key countries like China and India. Governments are expanding access via teleophthalmology networks and mobile clinics, while local innovation and affordable device production enhance adoption in underserved areas. Technological adoption, particularly OCT, AI tools, and multimodal platforms, is accelerating region-wide growth. A breakdown of the primary participants (supply-side) for the ophthalmic imaging market referred to in this report is provided below: • By Company Type: Tier 1:34%, Tier 2: 38%, and Tier 3: 28% • By Designation: C-level: 26%, Director Level: 35%, and Others: 39% • By Region: North America: 17%, Europe: 39%, Asia Pacific: 28%, Latin America: 8%, Middle East & Africa: 3%, GCC Countries: 5% Prominent players in the ophthalmic imaging market are Carl Zeiss Meditec AG (Germany), Topcon Corporation (Japan), Nidek Co. Ltd. (Japan), Alcon Inc. (Switzerland), Optopol Technology Sp. z o.o (Poland), Essilor International S.A. (France), Bausch & Lomb Incorporated (US), and Halma Plc (UK), among others. Research Coverage The report evaluates the ophthalmic imaging market and estimates its size and future growth potential based on various segments, including products, applications, end users, and regions. The report also includes a competitive analysis of the major players in this market, along with company profiles, product offerings, recent developments, and key market strategies. Reasons to Buy the Report The report will assist the market leader/new entrants in the market with data on the nearest approximations of the revenue numbers for the overall ophthalmic imaging market and the subsegments. The report will assist stakeholders in understanding the competitive landscape and gain further insights into better placing their businesses and making appropriate go-to-market strategies. The report assists the stakeholders in understanding the market pulse and gives them data on influential drivers, hindrances, obstacles, and opportunities in the market. This report provides insights into the following points:  Analysis of key drivers (Rising number of preterm and low-weight births, Public-private initiatives to strengthen patient care, Increasing incidence of HAIs among newborns, Changing clinical risks for congenital and obstetric complications, Rising number of neonatal care facilities worldwide), restraints (Premium pricing of advanced neonatal care equipment, Growing preference for refurbished devices across emerging countries), opportunities (Development of integrated and multifunctional neonatal care equipment, Market opportunities in emerging markets) and challenges (Limited access in low-income regions, Regulatory and compliance complexities) • Product Enhancement/Innovation: Comprehensive details about product launches and anticipated trends in the global ophthalmic imaging market • Market Development: Thorough knowledge and analysis of the profitable rising markets by product, application, end user, and region • Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global ophthalmic imaging market • Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings, and capacities of the major competitors in the global ophthalmic imaging market
目錄 Table of Contents
1 INTRODUCTION 33 1.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.3 STUDY SCOPE 34 1.3.1 OPHTHALMIC IMAGING MARKET SEGMENTATION & REGIONAL SCOPE 34 1.3.2 INCLUSIONS & EXCLUSIONS 35 1.3.3 YEARS CONSIDERED 36 1.3.4 CURRENCY CONSIDERED 36 1.4 STAKEHOLDERS 37 2 RESEARCH METHODOLOGY 38 2.1 RESEARCH DATA 38 2.1.1 SECONDARY DATA 38 2.1.1.1 Key sources of secondary data 39 2.1.1.2 Key data from secondary sources 40 2.1.2 PRIMARY DATA 40 2.1.2.1 Key sources of primary data 40 2.1.2.2 Key objectives of primary research 41 2.1.2.3 Key data from primary sources 41 2.1.2.4 Key industry insights 42 2.1.2.5 Breakdown of primary interviews 42 2.2 MARKET SIZE ESTIMATION 44 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 44 2.2.1.1 Company presentations and primary interviews 45 2.2.1.2 Demand-side analysis 46 2.2.1.3 Top-down approach 48 2.3 DATA TRIANGULATION 49 2.4 MARKET SHARE ESTIMATION 50 2.5 STUDY ASSUMPTIONS 51 2.6 RESEARCH LIMITATIONS 51 2.7 RISK ANALYSIS 52 3 EXECUTIVE SUMMARY 53   4 PREMIUM INSIGHTS 57 4.1 OPHTHALMIC IMAGING MARKET OVERVIEW 57 4.2 ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY AND COUNTRY (2024) 58 4.3 OPHTHALMIC IMAGING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 59 4.4 OPHTHALMIC IMAGING MARKET, REGIONAL MIX, 2023−2030 59 4.5 OPHTHALMIC IMAGING MARKET: EMERGING VS. DEVELOPED MARKETS 60 5 MARKET OVERVIEW 61 5.1 INTRODUCTION 61 5.2 MARKET DYNAMICS 61 5.2.1 DRIVERS 62 5.2.1.1 Growing prevalence of chronic eye diseases among geriatric patients 62 5.2.1.2 Technological advancements in imaging modalities 63 5.2.1.3 Favorable government initiatives and better reimbursement support 63 5.2.2 RESTRAINTS 64 5.2.2.1 High capital cost of ophthalmic imaging equipment 64 5.2.2.2 High maintenance costs and increased downtime of high-end systems 64 5.2.3 OPPORTUNITIES 64 5.2.3.1 High growth opportunities in emerging economies 64 5.2.3.2 Focus on AI-enabled screening and workflow optimization 65 5.2.4 CHALLENGES 65 5.2.4.1 Shortage of skilled ophthalmic technicians and clinicians 65 5.2.4.2 Data privacy and AI regulation challenges 66 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 66 5.4 PRICING ANALYSIS 67 5.4.1 AVERAGE SELLING PRICE OF OPHTHALMIC IMAGING PRODUCTS, BY TYPE, 2024 67 5.4.2 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 68 5.5 VALUE CHAIN ANALYSIS 69 5.6 SUPPLY CHAIN ANALYSIS 70 5.7 ECOSYSTEM ANALYSIS 71 5.7.1 ROLE IN ECOSYSTEM 72 5.8 INVESTMENT & FUNDING SCENARIO 73 5.9 TECHNOLOGY ANALYSIS 75 5.9.1 KEY TECHNOLOGIES 75 5.9.1.1 Fluorescein angiography 75 5.9.1.2 Ultrasound B-scan imaging 75 5.9.2 COMPLEMENTARY TECHNOLOGIES 75 5.9.2.1 Artificial intelligence and deep learning 75 5.9.3 ADJACENT TECHNOLOGIES 76 5.9.3.1 Smartphone-based retinal imaging 76 5.9.3.2 Gene therapy & retinal implants 76 5.10 INDUSTRY TRENDS 76 5.10.1 RAPID SHIFT TOWARD MULTIMODAL AND AI-INTEGRATED IMAGING SYSTEMS 76 5.10.2 INCREASED PENETRATION OF PORTABLE AND HANDHELD IMAGING SOLUTIONS 77 5.10.3 PREMIUM IMAGING GROWTH TO GET HIGH CAPITAL INVESTMENTS IN HOSPITALS AND TERTIARY CARE CENTERS 77 5.10.4 OEM CONSOLIDATION AND SOFTWARE-DRIVEN ECOSYSTEMS TO RESHAPE COMPETITIVE LANDSCAPE 77 5.11 PATENT ANALYSIS 77 5.12 TRADE ANALYSIS 79 5.12.1 IMPORT DATA FOR HS CODE 901850, 2020–2024 79 5.12.2 EXPORT DATA FOR HS CODE 901850, 2020–2024 80 5.13 KEY CONFERENCES & EVENTS, 2025–2026 81 5.14 CASE STUDY ANALYSIS 82 5.14.1 ZEISS TO ENHANCE CIRRUS HD-OCT PLATFORM BY INTEGRATING AI-BASED TOOLS FOR DETECTING GLAUCOMA AND RETINAL DISEASES 82 5.14.2 INDIA’S NATIONAL PROGRAM FOR CONTROL OF BLINDNESS (NPCB) TO COLLABORATE WITH FORUS HEALTH FOR REDUCING AVOIDABLE BLINDNESS 82 5.14.3 UK NATIONAL HEALTH SERVICE TO DEPLOY HEIDELBERG ENGINEERING’S SPECTRALIS OCT PLATFORM FOR IMPROVING EARLY DETECTION OF CHRONIC DISEASES 83 5.15 REGULATORY ANALYSIS 83 5.15.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 5.15.2 REGULATORY FRAMEWORK 85 5.15.2.1 North America 85 5.15.2.1.1 US 85 5.15.2.1.2 Canada 86 5.15.2.2 Europe 86 5.15.2.2.1 Germany 86 5.15.2.2.2 France 86 5.15.2.2.3 UK 86 5.15.2.3 Asia Pacific 86 5.15.2.3.1 China 86 5.15.2.3.2 Japan 87 5.15.2.3.3 India 87 5.15.2.4 Latin America 87 5.15.2.4.1 Brazil 87 5.15.2.4.2 Mexico 87 5.15.2.5 Middle East & Africa 87 5.15.2.5.1 Saudi Arabia 87 5.15.2.5.2 UAE 88 5.15.2.5.3 South Africa 88 5.15.2.5.4 Nigeria 88 5.16 PORTER’S FIVE FORCES ANALYSIS 88 5.16.1 BARGAINING POWER OF SUPPLIERS 90 5.16.2 BARGAINING POWER OF BUYERS 90 5.16.3 THREAT OF NEW ENTRANTS 90 5.16.4 THREAT OF SUBSTITUTES 90 5.16.5 INTENSITY OF COMPETITIVE RIVALRY 90 5.17 KEY STAKEHOLDERS & BUYING CRITERIA 91 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 91 5.17.2 KEY BUYING CRITERIA 92 5.18 UNMET NEEDS/END-USER EXPECTATIONS 92 5.19 IMPACT OF 2025 US TARIFF ON OPHTHALMIC IMAGING MARKET 94 5.19.1 KEY TARIFF RATES 95 5.19.2 PRICE IMPACT ANALYSIS 96 5.19.3 KEY IMPACT ON COUNTRY/REGION 96 5.19.3.1 North America 96 5.19.3.1.1 US 96 5.19.3.2 Europe 97 5.19.3.3 Asia Pacific 97 5.19.4 IMPACT ON END-USE INDUSTRIES 97 5.20 IMPACT OF AI/ GEN AI ON OPHTHALMIC IMAGING MARKET 97 5.21 ADJACENT MARKET ANALYSIS 98 6 OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY 99 6.1 INTRODUCTION 100 6.2 AI-ENABLED EQUIPMENT 100 6.2.1 RISING DEMAND FOR EARLY DIAGNOSIS, EFFICIENCY, AND STANDARDIZATION TO DRIVE MARKET 100 6.3 NON-AI-ENABLED EQUIPMENT 104 6.3.1 ESTABLISHED CLINICAL UTILITY AND COST-EFFECTIVENESS TO SUSTAIN DOMINANCE 104 7 OPHTHALMIC IMAGING MARKET, BY PRODUCT 106 7.1 INTRODUCTION 107 7.2 OPTICAL COHERENCE TOMOGRAPHY SYSTEMS 107 7.2.1 SPECTRAL-DOMAIN OCT (SD-OCT) 109 7.2.1.1 Growing demand for high-resolution retinal imaging to accelerate market adoption 109 7.2.2 SWEPT-SOURCE OCT (SS-OCT) 110 7.2.2.1 Rising preference for deep tissue imaging and faster scanning to fuel market growth 110   7.2.3 HANDHELD OCT 112 7.2.3.1 Surging demand for portability and pediatric imaging to propel market growth 112 7.3 OPHTHALMIC ULTRASOUND SYSTEMS 113 7.3.1 OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS 115 7.3.1.1 Rising prevalence of cataracts and increasing intraocular lens (IOL) implantation procedures to aid market growth 115 7.3.2 OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS 116 7.3.2.1 Rising incidence of retinal disorders and opaque media cases to augment segment growth 116 7.3.3 OPHTHALMIC ULTRASOUND BIOMICROSCOPES 118 7.3.3.1 Demand for high-resolution anterior segment imaging to fuel market growth 118 7.3.4 OPHTHALMIC PACHYMETERS 119 7.3.4.1 Growing incidence of glaucoma and increasing demand for refractive surgery to support segment growth 119 7.3.5 OTHER OPHTHALMIC ULTRASOUND SYSTEMS 121 7.4 FUNDUS CAMERAS 122 7.4.1 MYDRIATIC FUNDUS CAMERAS 124 7.4.1.1 Advancements in retinal disease diagnosis and imaging precision to boost market growth 124 7.4.2 NON-MYDRIATIC FUNDUS CAMERAS 126 7.4.2.1 Rising diabetic retinopathy screening and growing focus on primary eye care to augment market growth 126 7.4.3 HYBRID FUNDUS CAMERAS 127 7.4.3.1 Demand for versatile retinal imaging and workflow efficiency to fuel market adoption 127 7.4.4 ROP FUNDUS CAMERAS 129 7.4.4.1 Urgent need for early detection of retinal disorders in newborns to propel segment growth 129 7.5 SLIT LAMPS 130 7.5.1 HANDHELD SLIT LAMPS 132 7.5.1.1 Portability, tele-ophthalmology, and field screening to fuel market demand 132 7.5.2 TABLE MOUNT SLIT LAMPS 134 7.5.2.1 Focus on precision diagnostics and need for better image clarity to augment market growth 134 7.6 SPECULAR MICROSCOPES 135 7.6.1 RISING NUMBER OF CORNEAL TRANSPLANTS AND CATARACT SURGERIES TO ACCELERATE MARKET DEMAND 135 7.7 TONOMETERS 137 7.7.1 APPLANATION TONOMETERS 139 7.7.1.1 Widespread clinical acceptance and diagnostic accuracy to aid market growth 139   7.7.2 REBOUND TONOMETERS 140 7.7.2.1 Adoption of rebound tonometers to gain preference for better portability and greater patient comfort 140 7.8 OPHTHALMOSCOPES 142 7.8.1 DIRECT OPHTHALMOSCOPES 144 7.8.1.1 Technological upgrades to sustain global demand for direct ophthalmoscopes 144 7.8.2 INDIRECT OPHTHALMOSCOPES 145 7.8.2.1 Growing demand in retinal care to increase product demand 145 7.9 RETINOSCOPES 147 7.9.1 RISING DEMAND AMONG PEDIATRIC, NON-VERBAL, AND UNCOOPERATIVE PATIENTS TO SUSTAIN DEMAND 147 7.10 OTHER OPHTHALMIC IMAGING PRODUCTS 149 8 OPHTHALMIC IMAGING MARKET, BY APPLICATION 151 8.1 INTRODUCTION 152 8.2 GLAUCOMA 152 8.2.1 NEED FOR EARLY DETECTION AND LONG-TERM MONITORING TO FUEL ADOPTION OF ADVANCED IMAGING MODALITIES 152 8.3 CATARACTS 153 8.3.1 INCREASING CATARACT SURGERIES AND PREOPERATIVE IMAGING TO SPUR DEMAND FOR DIAGNOSTIC OPHTHALMIC SYSTEMS 153 8.4 RETINOPATHIES 155 8.4.1 RISING DIABETIC AND HYPERTENSIVE POPULATION TO ACCELERATE DEMAND FOR ADVANCED RETINAL IMAGING SOLUTIONS 155 8.5 REFRACTIVE DISORDERS 156 8.5.1 RISING DEMAND FOR REFRACTIVE SURGERIES TO BOOST UPTAKE OF ADVANCED IMAGING SYSTEMS FOR PREOPERATIVE PLANNING 156 8.6 AGE-RELATED MACULAR DEGENERATION 157 8.6.1 AGING DEMOGRAPHICS AND INCREASED LIFESPAN TO PROPEL PREVALENCE OF AGE-RELATED MACULAR DEGENERATION 157 8.7 OTHER APPLICATIONS 158 9 OPHTHALMIC IMAGING MARKET, BY END USER 159 9.1 INTRODUCTION 160 9.2 HOSPITALS 160 9.2.1 RISING ADOPTION OF ADVANCED OPHTHALMIC DIAGNOSTICS TO AUGMENT MARKET GROWTH 160 9.3 OPHTHALMOLOGY CLINICS 161 9.3.1 USE OF HIGH-THROUGHPUT, AI-INTEGRATED, AND PORTABLE IMAGING DEVICES TO FUEL MARKET GROWTH 161 9.4 OPTOMETRY CLINICS 163 9.4.1 INCREASING PREVALENCE OF MYOPIA AND LIFESTYLE-RELATED VISION DISORDERS TO AID MARKET GROWTH 163 9.5 OTHER END USERS 164 10 OPHTHALMIC IMAGING MARKET, BY REGION 165 10.1 INTRODUCTION 166 10.2 NORTH AMERICA 166 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 167 10.2.2 US 172 10.2.2.1 US to dominate North American ophthalmic imaging market during forecast period 172 10.2.3 CANADA 177 10.2.3.1 Rising geriatric population with chronic eye diseases to propel market growth 177 10.3 EUROPE 181 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 181 10.3.2 GERMANY 186 10.3.2.1 Strong clinical infrastructure and favorable healthcare policies to boost market growth 186 10.3.3 FRANCE 191 10.3.3.1 Government-funded eye screening programs and widespread insurance coverage to accelerate market growth 191 10.3.4 UK 195 10.3.4.1 Popularity on national screening programs and focus on NHS-backed digital adoption to stabilize market growth 195 10.3.5 ITALY 200 10.3.5.1 High geriatric population and expansion of regional eye care programs to boost demand for ophthalmic imaging 200 10.3.6 SPAIN 204 10.3.6.1 Increased public investment in health screening programs to aid market growth 204 10.3.7 REST OF EUROPE 209 10.4 ASIA PACIFIC 213 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 213 10.4.2 JAPAN 219 10.4.2.1 Strong focus on preventive and advanced eye care infrastructure to augment market growth 219 10.4.3 CHINA 224 10.4.3.1 Popularity of large-scale eye screening programs and focus on advanced ophthalmic imaging infrastructure to drive market 224 10.4.4 INDIA 228 10.4.4.1 Rising diabetic population and increasing popularity of nationwide eye health programs to propel market growth 228 10.4.5 SOUTH KOREA 233 10.4.5.1 High-tech healthcare adoption and aging demographics to accelerate smart ophthalmic imaging integration 233 10.4.6 AUSTRALIA 237 10.4.6.1 Government-backed eye care programs and expanding teleophthalmology to propel market growth 237 10.4.7 REST OF ASIA PACIFIC 242 10.5 LATIN AMERICA 246 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 246 10.5.2 BRAZIL 251 10.5.2.1 Focus on public tele-ophthalmology initiatives and diagnostics to boost market growth 251 10.5.3 MEXICO 256 10.5.3.1 Increasing prevalence of diabetic eye disease and growing focus on digital health expansion to drive market 256 10.5.4 REST OF LATIN AMERICA 260 10.6 MIDDLE EAST & AFRICA 264 10.6.1 INCREASED HEALTHCARE MODERNIZATION AND FOCUS ON PUBLIC HEALTH INVESTMENTS TO AID MARKET GROWTH 264 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 264 10.7 GCC COUNTRIES 269 10.7.1 GOVERNMENT-LED HEALTHCARE DIGITALIZATION AND INCREASED DIABETES-LINKED VISION DISORDERS TO DRIVE MARKET 269 10.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 269 11 COMPETITIVE LANDSCAPE 274 11.1 INTRODUCTION 274 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 274 11.2.1 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN OPHTHALMIC IMAGING MARKET 274 11.3 REVENUE ANALYSIS, 2020–2024 276 11.4 MARKET SHARE ANALYSIS, 2024 277 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 278 11.5.1 STARS 278 11.5.2 EMERGING LEADERS 278 11.5.3 PERVASIVE PLAYERS 279 11.5.4 PARTICIPANTS 279 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 280 11.5.5.1 Company footprint 280 11.5.5.2 Region footprint 281 11.5.5.3 Product footprint 282 11.5.5.4 Application footprint 283 11.5.5.5 End-user footprint 284 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 285 11.6.1 PROGRESSIVE COMPANIES 285 11.6.2 RESPONSIVE COMPANIES 285 11.6.3 DYNAMIC COMPANIES 285 11.6.4 STARTING BLOCKS 285 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 287   11.6.5.1 Detailed list of key startups/SMEs 287 11.6.5.2 Competitive benchmarking of startups/SMEs 288 11.7 COMPANY VALUATION & FINANCIAL METRICS 289 11.7.1 FINANCIAL METRICS 289 11.7.2 COMPANY VALUATION 289 11.8 BRAND/PRODUCT COMPARISON 290 11.9 COMPETITIVE SCENARIO 291 11.9.1 PRODUCT LAUNCHES 291 11.9.2 DEALS 292 11.9.3 OTHER DEVELOPMENTS 292 12 COMPANY PROFILES 293 12.1 KEY PLAYERS 293 12.1.1 CARL ZEISS MEDITEC AG 293 12.1.1.1 Business overview 293 12.1.1.2 Products offered 294 12.1.1.3 Recent developments 295 12.1.1.3.1 Product launches & upgrades 295 12.1.1.3.2 Deals 295 12.1.1.4 MnM view 295 12.1.1.4.1 Right to win 295 12.1.1.4.2 Strategic choices 296 12.1.1.4.3 Weaknesses & competitive threats 296 12.1.2 TOPCON CORPORATION 297 12.1.2.1 Business overview 297 12.1.2.2 Products offered 298 12.1.2.3 Recent developments 299 12.1.2.3.1 Deals 299 12.1.2.3.2 Other developments 299 12.1.2.4 MnM view 299 12.1.2.4.1 Right to win 299 12.1.2.4.2 Strategic choices 300 12.1.2.4.3 Weaknesses & competitive threats 300 12.1.3 NIDEK CO., LTD. 301 12.1.3.1 Business overview 301 12.1.3.2 Products offered 301 12.1.3.3 MnM view 302 12.1.3.3.1 Right to win 302 12.1.3.3.2 Strategic choices 302 12.1.3.3.3 Weaknesses & competitive threats 302   12.1.4 HALMA PLC 303 12.1.4.1 Business overview 303 12.1.4.2 Products offered 305 12.1.4.3 MnM view 306 12.1.4.3.1 Right to win 306 12.1.4.3.2 Strategic choices 306 12.1.4.3.3 Weaknesses & competitive threats 306 12.1.5 ALCON 307 12.1.5.1 Business overview 307 12.1.5.2 Products offered 308 12.1.5.3 MnM view 308 12.1.5.3.1 Right to win 308 12.1.5.3.2 Strategic choices 308 12.1.5.3.3 Weaknesses & competitive threats 309 12.1.6 HEIDELBERG ENGINEERING GMBH 310 12.1.6.1 Business overview 310 12.1.6.2 Products offered 310 12.1.7 HAAG-STREIT GROUP 311 12.1.7.1 Business overview 311 12.1.7.2 Products offered 311 12.1.8 CANON MEDICAL SYSTEMS CORPORATION 312 12.1.8.1 Business overview 312 12.1.8.2 Products offered 313 12.1.9 ESSILORLUXOTTICA 314 12.1.9.1 Business overview 314 12.1.9.2 Products offered 314 12.1.10 OCULUS 315 12.1.10.1 Business overview 315 12.1.10.2 Products offered 315 12.1.10.3 Recent developments 316 12.1.10.3.1 Product launches 316 12.1.11 VISIONIX 317 12.1.11.1 Business overview 317 12.1.11.2 Products offered 317 12.1.11.3 Recent developments 318 12.1.11.3.1 Deals 318 12.1.12 SONOMED ESCALON 319 12.1.12.1 Business overview 319 12.1.12.2 Products offered 319 12.1.13 COBURN TECHNOLOGIES, INC. 320 12.1.13.1 Business overview 320 12.1.13.2 Products offered 320 12.1.13.3 Recent developments 321 12.1.13.3.1 Product launches 321 12.1.14 DGH TECHNOLOGY, INC. 322 12.1.14.1 Business overview 322 12.1.14.2 Products offered 322 12.1.15 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD. 323 12.1.15.1 Business overview 323 12.1.15.2 Products offered 323 12.2 OTHER PLAYERS 324 12.2.1 VISUNEX MEDICAL SYSTEMS 324 12.2.2 FORUS HEALTH PVT. LTD. 325 12.2.3 ZIEMER OPHTHALMIC SYSTEMS AG 326 12.2.4 EYENUK INC. 327 12.2.5 COSTRUZIONE STRUMENTI OFTALMICI (CSO) 328 12.2.6 HAI LABORATORIES, INC. 329 12.2.7 CRYSTALVUE MEDICAL CORPORATION 330 12.2.8 SUZHOU KANGJIE MEDICAL INC. 331 12.2.9 KONAN MEDICAL USA, INC. 332 12.2.10 REMIDIO INNOVATIVE SOLUTIONS PVT. LTD. 333 13 APPENDIX 334 13.1 DISCUSSION GUIDE 334 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 340 13.3 CUSTOMIZATION OPTIONS 342 13.4 RELATED REPORTS 342 13.5 AUTHOR DETAILS 343
圖表清單 List of Tables & Figures
TABLE 1 OPHTHALMIC IMAGING MARKET: INCLUSIONS & EXCLUSIONS 35 TABLE 2 STANDARD CURRENCY CONVERSION RATES FROM USD, 2020–2024 36 TABLE 3 OPHTHALMIC IMAGING MARKET: STUDY ASSUMPTIONS 51 TABLE 4 OPHTHALMIC IMAGING MARKET: RISK ANALYSIS 52 TABLE 5 OPHTHALMIC IMAGING MARKET: IMPACT OF ANALYSIS OF MARKET DYNAMICS 62 TABLE 6 AVERAGE SELLING PRICE OF OPHTHALMIC IMAGING PRODUCTS, BY TYPE, 2024 (USD) 67 TABLE 7 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 (USD) 68 TABLE 8 OPHTHALMIC IMAGING MARKET: ROLE IN ECOSYSTEM 72 TABLE 9 IMPORT DATA FOR HS CODE 901850, BY COUNTRY, 2020–2024 (USD THOUSAND) 79 TABLE 10 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2020–2024 (USD THOUSAND) 80 TABLE 11 OPHTHALMIC IMAGING MARKET: LIST OF KEY CONFERENCES & EVENTS, JANAURY 2025–DECEMBER 2026 81 TABLE 12 CASE STUDY 1: ZEISS TO ENHANCE CIRRUS HD-OCT PLATFORM BY INTEGRATING AI-BASED TOOLS FOR DETECTING GLAUCOMA AND RETINAL DISEASES 82 TABLE 13 CASE STUDY 2: INDIA’S NATIONAL PROGRAM FOR CONTROL OF BLINDNESS (NPCB) TO COLLABORATE WITH FORUS HEALTH FOR REDUCING AVOIDABLE BLINDNESS 82 TABLE 14 CASE STUDY 3: UK NATIONAL HEALTH SERVICE TO DEPLOY HEIDELBERG ENGINEERING’S SPECTRALIS OCT PLATFORM FOR IMPROVING EARLY DETECTION OF CHRONIC DISEASES 83 TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85 TABLE 20 OPHTHALMIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 89 TABLE 21 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS (%) 91 TABLE 22 KEY BUYING CRITERIA FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS 92 TABLE 23 US-ADJUSTED RECIPROCAL TARIFF RATES 95 TABLE 24 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR OPHTHALMIC IMAGING 96 TABLE 25 OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 100 TABLE 26 R&D ACTIVITIES IN AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT 101 TABLE 27 EXAMPLES OF AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT AVAILABLE IN MARKET 102 TABLE 28 AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 29 EXAMPLES OF NON-AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT AVAILABLE IN MARKET 104 TABLE 30 NON-AI-ENABLED OPHTHALMIC IMAGING EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 31 OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 107 TABLE 32 OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 108 TABLE 33 OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 34 OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS) 109 TABLE 35 EXAMPLES OF SPECTRAL-DOMAIN OCT (SD-OCT) AVAILABLE IN MARKET 109 TABLE 36 SPECTRAL-DOMAIN OCT (SD-OCT) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 37 EXAMPLES OF SWEPT-SOURCE OCT (SS-OCT) AVAILABLE IN MARKET 111 TABLE 38 SWEPT-SOURCE OCT (SS-OCT) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 39 EXAMPLES OF HANDHELD OCT AVAILABLE IN MARKET 112 TABLE 40 HANDHELD OCT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 41 OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 114 TABLE 42 OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 43 OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY REGION, 2023–2030 (UNITS) 115 TABLE 44 EXAMPLES OF OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS AVAILABLE IN MARKET 115 TABLE 45 OPHTHALMIC A-SCAN ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116 TABLE 46 EXAMPLES OF OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS AVAILABLE IN MARKET 117 TABLE 47 OPHTHALMIC B-SCAN ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 48 EXAMPLES OF OPHTHALMIC ULTRASOUND BIOMICROSCOPES AVAILABLE IN MARKET 118 TABLE 49 OPHTHALMIC ULTRASOUND BIOMICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 50 EXAMPLES OF OPHTHALMIC PACHYMETERS AVAIALBLE IN MARKET 120 TABLE 51 OPHTHALMIC PACHYMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 52 EXAMPLES OF OTHER OPHTHALMIC ULTRASOUND SYSTEMS AVAILABLE IN MARKET 121 TABLE 53 OTHER OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 54 FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 123 TABLE 55 FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 56 FUNDUS CAMERAS MARKET, BY REGION, 2023–2030 (UNITS) 124 TABLE 57 EXAMPLES OF MYDRIATIC FUNDUS CAMERAS AVAILABLE IN MARKET 125 TABLE 58 MYDRIATIC FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 59 EXAMPLES OF NON-MYDRIATIC FUNDUS CAMERAS AVAILABLE IN MARKET 126 TABLE 60 NON-MYDRIATIC FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 127 TABLE 61 EXAMPLES OF HYBRID FUNDUS CAMERAS AVAILABLE IN MARKET 128 TABLE 62 HYBRID FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 63 EXAMPLES OF ROP FUNDUS CAMERAS AVAILABLE IN MARKET 129 TABLE 64 ROP FUNDUS CAMERAS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130 TABLE 65 SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 131 TABLE 66 SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 67 SLIT LAMPS MARKET, BY REGION, 2023–2030 (UNITS) 132 TABLE 68 EXAMPLES OF HANDHELD SLIT LAMPS AVAILABLE IN MARKET 133 TABLE 69 HANDHELD SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 70 EXAMPLES OF TABLE MOUNT SLIT LAMPS AVAILABLE IN MARKET 134 TABLE 71 TABLE MOUNT SLIT LAMPS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 72 SPECULAR MICROSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 73 SPECULAR MICROSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 136 TABLE 74 TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 137 TABLE 75 TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 76 TONOMETERS MARKET, BY REGION, 2023–2030 (UNITS) 138 TABLE 77 EXAMPLES OF APPLANATION TONOMETERS AVAILABLE IN MARKET 139 TABLE 78 APPLANATION TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 79 EXAMPLES OF REBOUND TONOMETERS AVAILABLE IN MARKET 141 TABLE 80 REBOUND TONOMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 81 OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 142 TABLE 82 OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 83 OPHTHALMOSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 143 TABLE 84 EXAMPLES OF DIRECT OPHTHALMOSCOPES AVAILABLE IN MARKET 144 TABLE 85 DIRECT OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 86 EXAMPLES OF INDIRECT OPHTHALMOSCOPES AVAILABLE IN MARKET 146 TABLE 87 INDIRECT OPHTHALMOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 88 EXAMPLES OF RETINOSCOPES AVAILABLE IN MARKET 147 TABLE 89 RETINOSCOPES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 90 RETINOSCOPES MARKET, BY REGION, 2023–2030 (UNITS) 148 TABLE 91 EXAMPLES OF OTHER OPHTHALMIC IMAGING PRODUCTS AVAILABLE IN MARKET 149 TABLE 92 OTHER OPHTHALMIC IMAGING PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 93 OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 152 TABLE 94 OPHTHALMIC IMAGING MARKET FOR GLAUCOMA, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 95 OPHTHALMIC IMAGING MARKET FOR CATARACTS, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 96 OPHTHALMIC IMAGING MARKET FOR RETINOPATHIES, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 97 OPHTHALMIC IMAGING MARKET FOR REFRACTIVE DISORDERS, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 98 OPHTHALMIC IMAGING MARKET FOR AGE-RELATED MACULAR DEGENERATION, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 99 OPHTHALMIC IMAGING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 100 OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 101 OPHTHALMIC IMAGING MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 161 TABLE 102 OPHTHALMIC IMAGING MARKET FOR OPHTHALMOLOGY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 103 OPHTHALMIC IMAGING MARKET FOR OPTOMETRY CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 104 OPHTHALMIC IMAGING MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 105 OPHTHALMIC IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 106 NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 107 NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 168 TABLE 108 NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 169 TABLE 109 NORTH AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 110 NORTH AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 111 NORTH AMERICA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 112 NORTH AMERICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 113 NORTH AMERICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 114 NORTH AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 171 TABLE 115 NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 171 TABLE 116 NORTH AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 172 TABLE 117 US: KEY MACROINDICATORS 172 TABLE 118 US: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 173 TABLE 119 US: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 173 TABLE 120 US: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 121 US: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 174 TABLE 122 US: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 123 US: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 124 US: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 125 US: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 176 TABLE 126 US: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176 TABLE 127 US: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 128 CANADA: KEY MACROINDICATORS 177 TABLE 129 CANADA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 177 TABLE 130 CANADA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 178 TABLE 131 CANADA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 132 CANADA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 133 CANADA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 134 CANADA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 179 TABLE 135 CANADA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 136 CANADA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 137 CANADA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 180 TABLE 138 CANADA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 181 TABLE 139 EUROPE: OPHTHALMIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 140 EUROPE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 182 TABLE 141 EUROPE: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 183 TABLE 142 EUROPE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 143 EUROPE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 144 EUROPE: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 145 EUROPE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 146 EUROPE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 147 EUROPE: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 148 EUROPE: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 185 TABLE 149 EUROPE: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 186 TABLE 150 GERMANY: KEY MACROINDICATORS 187 TABLE 151 GERMANY: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 187 TABLE 152 GERMANY: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 187 TABLE 153 GERMANY: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 154 GERMANY: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 155 GERMANY: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 156 GERMANY: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 157 GERMANY: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 158 GERMANY: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 159 GERMANY: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 190 TABLE 160 GERMANY: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 161 FRANCE: KEY MACROINDICATORS 191 TABLE 162 FRANCE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 191 TABLE 163 FRANCE: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 192 TABLE 164 FRANCE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 192 TABLE 165 FRANCE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 166 FRANCE: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 167 FRANCE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 168 FRANCE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 169 FRANCE: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 170 FRANCE: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 194 TABLE 171 FRANCE: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 195 TABLE 172 UK: KEY MACROINDICATORS 195 TABLE 173 UK: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 196 TABLE 174 UK: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196 TABLE 175 UK: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 176 UK: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 177 UK: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 178 UK: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 179 UK: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 198 TABLE 180 UK: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 199 TABLE 181 UK: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 199 TABLE 182 UK: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 199 TABLE 183 ITALY: KEY MACROINDICATORS 200 TABLE 184 ITALY: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 200 TABLE 185 ITALY: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 201 TABLE 186 ITALY: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 187 ITALY: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 188 ITALY: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 189 ITALY: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 190 ITALY: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 191 ITALY: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 203 TABLE 192 ITALY: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 203 TABLE 193 ITALY: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 204 TABLE 194 SPAIN: KEY MACROINDICATORS 204 TABLE 195 SPAIN: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 205 TABLE 196 SPAIN: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 205 TABLE 197 SPAIN: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 198 SPAIN: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 206 TABLE 199 SPAIN: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 200 SPAIN: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 201 SPAIN: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 202 SPAIN: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 203 SPAIN: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 208 TABLE 204 SPAIN: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 208 TABLE 205 REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 209 TABLE 206 REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 210 TABLE 207 REST OF EUROPE: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 208 REST OF EUROPE: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 209 REST OF EUROPE: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 210 REST OF EUROPE: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 211 REST OF EUROPE: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 212 REST OF EUROPE: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 212 TABLE 213 REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 212 TABLE 214 REST OF EUROPE: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 213 TABLE 215 ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 216 ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 215 TABLE 217 ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 216 TABLE 218 ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 216 TABLE 219 ASIA PACIFIC: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 220 ASIA PACIFIC: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 221 ASIA PACIFIC: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 222 ASIA PACIFIC: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 223 ASIA PACIFIC: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 224 ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 218 TABLE 225 ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 219 TABLE 226 JAPAN: KEY MACROINDICATORS 219 TABLE 227 JAPAN: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 220 TABLE 228 JAPAN: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 220 TABLE 229 JAPAN: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 230 JAPAN: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 231 JAPAN: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 232 JAPAN: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 233 JAPAN: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 234 JAPAN: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 235 JAPAN: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 223 TABLE 236 JAPAN: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 223 TABLE 237 CHINA: KEY MACROINDICATORS 224 TABLE 238 CHINA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 224 TABLE 239 CHINA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 225 TABLE 240 CHINA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 241 CHINA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 242 CHINA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 243 CHINA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 244 CHINA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 245 CHINA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 246 CHINA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 227 TABLE 247 CHINA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 228 TABLE 248 INDIA: KEY MACROINDICATORS 228 TABLE 249 INDIA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 229 TABLE 250 INDIA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 229 TABLE 251 INDIA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 252 INDIA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 230 TABLE 253 INDIA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 254 INDIA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 255 INDIA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 256 INDIA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 257 INDIA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 232 TABLE 258 INDIA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 232 TABLE 259 SOUTH KOREA: KEY MACROINDICATORS 233 TABLE 260 SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 233 TABLE 261 SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 234 TABLE 262 SOUTH KOREA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 263 SOUTH KOREA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 264 SOUTH KOREA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 265 SOUTH KOREA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 266 SOUTH KOREA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 267 SOUTH KOREA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 268 SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 236 TABLE 269 SOUTH KOREA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 237 TABLE 270 AUSTRALIA: KEY MACROINDICATORS 237 TABLE 271 AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 238 TABLE 272 AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 238 TABLE 273 AUSTRALIA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 274 AUSTRALIA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 275 AUSTRALIA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 276 AUSTRALIA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 277 AUSTRALIA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 278 AUSTRALIA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 279 AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 241 TABLE 280 AUSTRALIA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 241 TABLE 281 REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 242 TABLE 282 REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 243 TABLE 283 REST OF ASIA PACIFIC: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 284 REST OF ASIA PACIFIC: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 285 REST OF ASIA PACIFIC: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 286 REST OF ASIA PACIFIC: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 287 REST OF ASIA PACIFIC: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 288 REST OF ASIA PACIFIC: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 245 TABLE 289 REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 245 TABLE 290 REST OF ASIA PACIFIC: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 246 TABLE 291 LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 247 TABLE 292 LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 247 TABLE 293 LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 248 TABLE 294 LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 295 LATIN AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 296 LATIN AMERICA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 297 LATIN AMERICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 298 LATIN AMERICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 299 LATIN AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 300 LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 250 TABLE 301 LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 251 TABLE 302 BRAZIL: KEY MACROINDICATORS 251 TABLE 303 BRAZIL: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 252 TABLE 304 BRAZIL: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 252 TABLE 305 BRAZIL: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 306 BRAZIL: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 307 BRAZIL: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 308 BRAZIL: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 309 BRAZIL: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 310 BRAZIL: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 311 BRAZIL: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 255 TABLE 312 BRAZIL: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 255 TABLE 313 MEXICO: KEY MACROINDICATORS 256 TABLE 314 MEXICO: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 256 TABLE 315 MEXICO: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 257 TABLE 316 MEXICO: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 317 MEXICO: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 318 MEXICO: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 319 MEXICO: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 320 MEXICO: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 321 MEXICO: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 322 MEXICO: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 259 TABLE 323 MEXICO: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 260 TABLE 324 REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 260 TABLE 325 REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 261 TABLE 326 REST OF LATIN AMERICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 327 REST OF LATIN AMERICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 328 REST OF LATIN AMERICA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 329 REST OF LATIN AMERICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 330 REST OF LATIN AMERICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 331 REST OF LATIN AMERICA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 332 REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 263 TABLE 333 REST OF LATIN AMERICA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 264 TABLE 334 MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 265 TABLE 335 MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 265 TABLE 336 MIDDLE EAST & AFRICA: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 337 MIDDLE EAST & AFRICA: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 338 MIDDLE EAST & AFRICA: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 339 MIDDLE EAST & AFRICA: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 340 MIDDLE EAST & AFRICA: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 341 MIDDLE EAST & AFRICA: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 342 MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 268 TABLE 343 MIDDLE EAST & AFRICA: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 269 TABLE 344 GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION) 270 TABLE 345 GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 270 TABLE 346 GCC COUNTRIES: OPTICAL COHERENCE TOMOGRAPHY SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 347 GCC COUNTRIES: OPHTHALMIC ULTRASOUND SYSTEMS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 348 GCC COUNTRIES: FUNDUS CAMERAS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 349 GCC COUNTRIES: SLIT LAMPS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 350 GCC COUNTRIES: TONOMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 351 GCC COUNTRIES: OPHTHALMOSCOPES MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 352 GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 273 TABLE 353 GCC COUNTRIES: OPHTHALMIC IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 273 TABLE 354 KEY STRATEGIES DEPLOYED BY MAJOR PLAYERS IN OPHTHALMIC IMAGING MARKET, JANUARY 2021–JULY 2025 274 TABLE 355 OPHTHALMIC IMAGING MARKET: DEGREE OF COMPETITION 277 TABLE 356 OPHTHALMIC IMAGING MARKET: REGION FOOTPRINT 281 TABLE 357 OPHTHALMIC IMAGING MARKET: PRODUCT FOOTPRINT 282 TABLE 358 OPHTHALMIC IMAGING MARKET: APPLICATION FOOTPRINT 283 TABLE 359 OPHTHALMIC IMAGING MARKET: END-USER FOOTPRINT 284 TABLE 360 OPHTHALMIC IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 287 TABLE 361 OPHTHALMIC IMAGING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY APPLICATION AND REGION 288 TABLE 362 OPHTHALMIC IMAGING MARKET: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 291 TABLE 363 OPHTHALMIC IMAGING MARKET: DEALS, JANUARY 2021–JULY 2025 292 TABLE 364 OPHTHALMIC IMAGING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2025 292 TABLE 365 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW 293 TABLE 366 CARL ZEISS MEDITEC AG: PRODUCTS OFFERED 294 TABLE 367 CARL ZEISS MEDITEC AG: PRODUCT LAUNCHES & UPGRADES, JANUARY 2021–JULY 2025 295 TABLE 368 CARL ZEISS MEDITEC AG: DEALS, JANUARY 2021–JULY 2025 295 TABLE 369 TOPCON CORPORATION: COMPANY OVERVIEW 297 TABLE 370 TOPCON CORPORATION: PRODUCTS OFFERED 298 TABLE 371 TOPOCON CORPORATION: DEALS, JANUARY 2021–JULY 2025 299 TABLE 372 TOPOCON CORPORATION: OTHER DEVELOPMENTS, JANUARY 2021–JULY 2025 299 TABLE 373 NIDEK CO., LTD.: COMPANY OVERVIEW 301 TABLE 374 NIDEK CO., LTD.: PRODUCTS OFFERED 301 TABLE 375 HALMA PLC: COMPANY OVERVIEW 303 TABLE 376 HALMA PLC: PRODUCTS OFFERED 305 TABLE 377 ALCON: COMPANY OVERVIEW 307 TABLE 378 ALCON: PRODUCTS OFFERED 308 TABLE 379 HEIDELBERG ENGINEERING GMBH: COMPANY OVERVIEW 310 TABLE 380 HEIDELBERG ENGINEERING GMBH: PRODUCTS OFFERED 310 TABLE 381 HAAG-STREIT GROUP: COMPANY OVERVIEW 311 TABLE 382 HAAG-STREIT GROUP: PRODUCTS OFFERED 311 TABLE 383 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 312 TABLE 384 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 313 TABLE 385 ESSILORLUXOTTICA: COMPANY OVERVIEW 314 TABLE 386 ESSILORLUXOTTICA: PRODUCTS OFFERED 314 TABLE 387 OCULUS: COMPANY OVERVIEW 315 TABLE 388 OCULUS: PRODUCTS OFFERED 315 TABLE 389 OCULUS: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 316 TABLE 390 VISIONIX: COMPANY OVERVIEW 317 TABLE 391 VISIONIX: PRODUCTS OFFERED 317 TABLE 392 VISIONIX: DEALS, JANUARY 2021–JULY 2025 318 TABLE 393 SONOMED ESCALON: COMPANY OVERVIEW 319 TABLE 394 SONOMED ESCALON: PRODUCTS OFFERED 319 TABLE 395 COBURN TECHNOLOGIES, INC.: COMPANY OVERVIEW 320 TABLE 396 COBURN TECHNOLOGIES, INC.: PRODUCTS OFFERED 320 TABLE 397 COBURN TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2021–JULY 2025 321 TABLE 398 DGH TECHNOLOGY, INC.: COMPANY OVERVIEW 322 TABLE 399 DGH TECHNOLOGY, INC.: PRODUCTS OFFERED 322 TABLE 400 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.: COMPANY OVERVIEW 323 TABLE 401 SHANGHAI MEDIWORKS PRECISION INSTRUMENTS CO., LTD.: PRODUCTS OFFERED 323 TABLE 402 VISUNEX MEDICAL SYSTEMS: COMPANY OVERVIEW 324 TABLE 403 FORUS HEALTH PVT. LTD.: COMPANY OVERVIEW 325 TABLE 404 ZIEMER OPHTHALMIC SYSTEMS AG: COMPANY OVERVIEW 326 TABLE 405 EYENUK INC.: COMPANY OVERVIEW 327 TABLE 406 COSTRUZIONE STRUMENTI OFTALMICI (CSO): COMPANY OVERVIEW 328 TABLE 407 HAI LABORATORIES, INC.: COMPANY OVERVIEW 329 TABLE 408 CRYSTALVUE MEDICAL CORPORATION: COMPANY OVERVIEW 330 TABLE 409 SUZHOU KANGJIE MEDICAL INC.: COMPANY OVERVIEW 331 TABLE 410 KONAN MEDICAL USA, INC.: COMPANY OVERVIEW 332 TABLE 411 REMIDIO INNOVATIVE SOLUTIONS PVT. LTD.: COMPANY OVERVIEW 333 FIGURE 1 OPHTHALMIC IMAGING MARKET SEGMENTATION & REGIONAL SCOPE 34 FIGURE 2 OPHTHALMIC IMAGING MARKET: YEARS CONSIDERED 36 FIGURE 3 OPHTHALMIC IMAGING MARKET: RESEARCH DESIGN 38 FIGURE 4 OPHTHALMIC IMAGING MARKET: KEY DATA FROM SECONDARY SOURCES 40 FIGURE 5 OPHTHALMIC IMAGING MARKET: KEY PRIMARY DATA SOURCES 40 FIGURE 6 OPHTHALMIC IMAGING MARKET: KEY DATA FROM PRIMARY SOURCES 41 FIGURE 7 OPHTHALMIC IMAGING MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 42 FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 42 FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 43 FIGURE 10 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 43 FIGURE 11 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44 FIGURE 12 REVENUE SHARE ANALYSIS ILLUSTRATION: CARL ZEISS MEDITEC AG (2024) 45 FIGURE 13 OPHTHALMIC IMAGING SUPPLY-SIDE MARKET SIZE ESTIMATION (2024) 46 FIGURE 14 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 47 FIGURE 15 OPHTHALMIC IMAGING MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS) 48 FIGURE 16 OPHTHALMIC IMAGING MARKET: TOP-DOWN APPROACH 49 FIGURE 17 OPHTHALMIC IMAGING MARKET: DATA TRIANGULATION METHODOLOGY 50 FIGURE 18 OPHTHALMIC IMAGING MARKET, BY TECHNOLOGY, 2025 VS. 2030 (USD MILLION) 53 FIGURE 19 OPHTHALMIC IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 54 FIGURE 20 OPHTHALMIC IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 55 FIGURE 21 OPHTHALMIC IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 55 FIGURE 22 REGIONAL SNAPSHOT OF OPHTHALMIC IMAGING MARKET 56 FIGURE 23 RISING ADOPTION OF ADVANCED OPHTHALMIC DIAGNOSTICS IN HOSPITALS TO BOOST DEMAND FOR INTEGRATED IMAGING SYSTEMS 57 FIGURE 24 CHINA AND NON-AI-ENABLED EQUIPMENT COMMANDED LARGEST ASIA PACIFIC MARKET SHARE IN 2024 58 FIGURE 25 INDIA TO REGISTER HIGHEST CAGR DURING STUDY PERIOD 59 FIGURE 26 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE FROM 2025 TO 2030 59 FIGURE 27 EMERGING MARKETS TO PROJECT HIGHER GROWTH RATES DURING STUDY PERIOD 60 FIGURE 28 OPHTHALMIC IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61 FIGURE 29 OPHTHALMIC IMAGING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67 FIGURE 30 AVERAGE SELLING PRICE TREND OF OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2022–2024 (USD) 68 FIGURE 31 OPHTHALMIC IMAGING MARKET: VALUE CHAIN ANALYSIS 69 FIGURE 32 OPHTHALMIC IMAGING MARKET: SUPPLY CHAIN ANALYSIS 71 FIGURE 33 OPHTHALMIC IMAGING MARKET: ECOSYSTEM ANALYSIS 72 FIGURE 34 OPHTHALMIC IMAGING MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023 (USD MILLION) 73 FIGURE 35 OPHTHALMIC IMAGING MARKET: VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 74 FIGURE 36 OPHTHALMIC IMAGING MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (UNITS) 74 FIGURE 37 OPHTHALMIC IMAGING MARKET: TOP 10 COMPANIES/APPLICANTS WITH HIGHEST NUMBER OF PATENT APPLIED/GRANTED, JANUARY 2015−JULY 2025 78 FIGURE 38 OPHTHALMIC IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 89 FIGURE 39 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS 91 FIGURE 40 KEY BUYING CRITERIA FOR TOP THREE OPHTHALMIC IMAGING PRODUCTS 92 FIGURE 41 IMPACT OF AI/GEN AI ON OPHTHALMIC IMAGING MARKET 98 FIGURE 42 MARKETS ADJACENT TO OPHTHALMIC IMAGING MARKET 98 FIGURE 43 NORTH AMERICA: OPHTHALMIC IMAGING MARKET SNAPSHOT 167 FIGURE 44 ASIA PACIFIC: OPHTHALMIC IMAGING MARKET SNAPSHOT 214 FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN OPHTHALMIC IMAGING MARKET, 2020–2024 (USD MILLION) 276 FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN OPHTHALMIC IMAGING MARKET (2024) 277 FIGURE 47 OPHTHALMIC IMAGING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 279 FIGURE 48 OPHTHALMIC IMAGING MARKET: COMPANY FOOTPRINT 280 FIGURE 49 OPHTHALMIC IMAGING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 286 FIGURE 50 EV/EBITDA OF KEY VENDORS 289 FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 289 FIGURE 52 OPHTHALMIC IMAGING MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 290 FIGURE 53 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT 294 FIGURE 54 TOPCON CORPORATION: COMPANY SNAPSHOT 298 FIGURE 55 HALMA PLC: COMPANY SNAPSHOT 304 FIGURE 56 ALCON: COMPANY SNAPSHOT 307 FIGURE 57 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT 313

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們